From January 1, 2024 to March 31, 2024, the company has repurchased 1,148,000 shares, representing 0.67% for CNY 13.11 million. With this, the company has completed the repurchase of 1,872,500 shares, representing 1.1% for CNY 22.08 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 CNY | -7.62% | -7.49% | -10.09% |
1st Jan change | Capi. | |
---|---|---|
-10.09% | 33Cr | |
+20.87% | 843.95Cr | |
+7.54% | 777.52Cr | |
+12.95% | 677.4Cr | |
-3.85% | 381.36Cr | |
-5.81% | 371.09Cr | |
+2.08% | 140.16Cr | |
-27.06% | 108.66Cr | |
+24.00% | 102.67Cr | |
-12.01% | 90Cr |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.